Home Ingredients goFAT® (Structured Lipid Blend)
Energy

goFAT® (Structured Lipid Blend)

Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

goFAT® (Compound Solutions) is a proprietary structured lipid blend combining medium-chain triglycerides (MCTs) with other functional fat sources to provide rapid-absorbing ketogenic fuel, fat-soluble nutrient delivery, and sustained energy without spiking blood glucose or insulin. Designed for ketogenic, low-carbohydrate, and performance nutrition applications where fat serves as the primary fuel substrate.

Studied Dose Per product label; typical fat blend 5–15g/day; MCT component provides rapid ketone substrate
Active Compound Proprietary structured lipid blend — MCT-based with functional fat sources; goFAT® by Compound Solutions; specific composition proprietary

Benefits

Rapid ketogenic fuel and energy

MCT-rich fat blends are rapidly absorbed and transported directly to the liver via portal circulation, bypassing lymphatic chylomicron packaging. Liver MCT metabolism rapidly generates ketone bodies (BHB, AcAc) that serve as immediate brain and muscle fuel — providing fast-acting energy without glucose or insulin dependency.

Supported by Trial 1

Ketosis support and metabolic flexibility

goFAT® supports nutritional ketosis in low-carbohydrate dieters by providing a concentrated, clean fat source that promotes ketone production. Combined with caloric deficit, the fat blend maintains energy availability while the body adapts to fat oxidation as its primary fuel source.

Supported by Trial 1

Fat-soluble nutrient delivery

Structured lipid blends enhance the absorption of fat-soluble vitamins (A, D, E, K) and fat-soluble bioactives (CoQ10, curcumin, resveratrol) by providing the dietary fat matrix required for micellar solubilization and lymphatic absorption. This makes goFAT® valuable as a carrier for lipophilic nutraceuticals.

Supported by Trial 1

Mechanism of action

1

Portal MCT absorption and hepatic ketogenesis

Medium-chain fatty acids (C8, C10, C12) bypass the lymphatic system and are absorbed directly via portal vein to the liver — bypassing the chylomicron packaging required for long-chain fats. In the liver, MCTs undergo rapid beta-oxidation to acetyl-CoA, which is converted to ketone bodies under low-carbohydrate conditions. This metabolic pathway provides faster energy availability than long-chain fats or carbohydrates.

Clinical trials

1
MCT Component Evidence — Limited Specific goFAT® Data
PubMed

There is no peer-reviewed clinical trial of goFAT® as a branded ingredient indexed in PubMed. The cited PMID 25636220 may be for a related MCT or structured lipid trial. Most evidence comes from generic MCT oil literature, which is not directly equivalent to goFAT®.

Limited specific goFAT® data; broader MCT literature.

MCT oil (the primary lipid component): consistent evidence for modest blood ketone elevation, modest appetite reduction, and improved cognitive performance in older adults with MCI. Critical caveat: 'goFAT®' specific evidence is limited; effects extrapolated from broader MCT literature. Buyers should obtain full clinical study reports from the manufacturer before relying on specific goFAT® claims.

Side effects and drug interactions

Common Potential side effects

GI distress (nausea, diarrhea) when MCT doses introduced too rapidly — increase gradually
High caloric density — account for fat calories in total daily intake
Not suitable for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency

Important Drug interactions

Fat-soluble drug absorption — high fat intake may alter absorption of lipophilic medications; take separately
No significant pharmacokinetic drug interactions at normal supplemental doses

More Energy Ingredients

Energy
Caffeine
Caffeine, a natural stimulant found in coffee, tea, and other plants, is commonly suppleme…
Cognitive
Vitamin B12
Vitamin B12, also known as cobalamin, is a water-soluble vitamin commonly supplemented as…
Energy
Iron
Iron is an essential mineral best known for its central role in making hemoglobin, the pro…
Hydration
Glucose / Dextrose
Glucose (also called dextrose in its pure crystalline form) is the body's primary fuel sug…

Explore Other Ingredients

Cognitive
Phosphatidylserine
Phosphatidylserine (PS) is a phospholipid concentrated in neuronal cell membranes (10-20%…
Athletic Performance
Cordyceps
Cordyceps is a medicinal mushroom traditionally prized as an energy and vitality tonic, po…
Antioxidant
NAC (N-Acetylcysteine)
NAC (N-Acetyl Cysteine) is a supplemental form of the amino acid cysteine, best known for…

Frequently asked questions about goFAT® (Structured Lipid Blend)

What is goFAT?

goFAT® (Compound Solutions) is a proprietary structured lipid blend combining medium-chain triglycerides (MCTs) with other functional fat sources to provide rapid-absorbing ketogenic fuel, fat-soluble nutrient delivery, and sustained energy without spiking blood glucose or insulin.

What is goFAT used for?

goFAT is researched primarily for Energy. MCT-rich fat blends are rapidly absorbed and transported directly to the liver via portal circulation, bypassing lymphatic chylomicron packaging.

What is the recommended dosage of goFAT?

The clinically studied dose is Per product label; typical fat blend 5–15g/day; MCT component provides rapid ketone substrate Always follow the product label and check with a healthcare provider for personal advice.

Is goFAT safe, and does it have side effects?

For most healthy adults, goFAT is well tolerated at studied doses. Reported effects can include: GI distress (nausea, diarrhea) when MCT doses introduced too rapidly — increase gradually High caloric density — account for fat calories in total daily intake It may also interact with some medications. goFAT is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does goFAT interact with any medications?

Possible interactions include: Fat-soluble drug absorption — high fat intake may alter absorption of lipophilic medications; take separately No significant pharmacokinetic drug interactions at normal supplemental doses If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for goFAT?

NutraSmarts rates the evidence for goFAT as Limited (2 out of 5). It is backed by 1 clinical trial and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Vandenberghe C, St-Pierre V, Pierotti T, Fortier M, Castellano CA, Cunnane SC Tricaprylin Alone Increases Plasma Ketone Response More Than Coconut Oil or Other Medium-Chain Triglycerides: An Acute Crossover Study in Healthy Adults. Current Developments in Nutrition. 2017;1(4):e000257. doi: 10.3945/cdn.116.000257.PubMedUsed to support: Acute crossover human study (healthy adults) showing pure C8 MCT (tricaprylin) raises plasma ketones 800%+ above control and more than coconut oil or other MCTs, directly supporting 'rapid ketogenic fuel and energy' and 'ketosis support' claims of goFAT®; MCT component evidence — no goFAT® brand trial exists.
  2. Courchesne-Loyer A, Lowry CM, St-Pierre V, Vandenberghe C, Fortier M, Castellano CA, Wagner JR, Cunnane SC Emulsification Increases the Acute Ketogenic Effect and Bioavailability of Medium-Chain Triglycerides in Humans: Protein, Carbohydrate, and Fat Metabolism. Current Developments in Nutrition. 2017;1(7):e000851. doi: 10.3945/cdn.117.000851.PubMedUsed to support: Human crossover study (n=10) showing emulsified MCT increases plasma ketones 2- to 4-fold in a dose-dependent manner and reduces GI side effects vs. non-emulsified MCT. Supports 'rapid ketogenic fuel and energy' and 'metabolic flexibility' claims; MCT component evidence.
  3. Cunnane SC, Courchesne-Loyer A, St-Pierre V, Vandenberghe C, Pierotti T, Fortier M, Croteau E, Castellano CA Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease. Annals of the New York Academy of Sciences. 2016;1367(1):12-20. doi: 10.1111/nyas.12999.PubMedUsed to support: Review synthesising human and clinical evidence that MCT-derived ketones can substitute for declining brain glucose uptake, supporting the 'rapid ketogenic fuel and energy' and 'fat-soluble nutrient delivery' positioning of goFAT®; MCT/ketone component literature.